Merck (MRK) Enterprise Value (2016 - 2025)
Merck (MRK) has disclosed Enterprise Value for 17 consecutive years, with -$14.6 billion as the latest value for Q4 2025.
- On a quarterly basis, Enterprise Value fell 6.86% to -$14.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$14.6 billion, a 6.86% decrease, with the full-year FY2025 number at -$14.6 billion, down 6.86% from a year prior.
- Enterprise Value was -$14.6 billion for Q4 2025 at Merck, up from -$18.1 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$5.5 billion in Q1 2024 to a low of -$18.1 billion in Q3 2025.
- A 5-year average of -$10.1 billion and a median of -$9.1 billion in 2022 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: skyrocketed 46.37% in 2023, then plummeted 100.29% in 2024.
- Merck's Enterprise Value stood at -$8.0 billion in 2021, then plummeted by 63.59% to -$13.1 billion in 2022, then skyrocketed by 46.37% to -$7.0 billion in 2023, then crashed by 93.64% to -$13.6 billion in 2024, then decreased by 6.86% to -$14.6 billion in 2025.
- Per Business Quant, the three most recent readings for MRK's Enterprise Value are -$14.6 billion (Q4 2025), -$18.1 billion (Q3 2025), and -$8.6 billion (Q2 2025).